Canada markets open in 4 hours 18 minutes

Resverlogix Corp. (RVX.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.9100-0.0600 (-6.19%)
At close: 3:59PM EST

Resverlogix Corp.

4820 Richard Road SW
Suite 300
Calgary, AB T3E 6L1
Canada
403 254 9252
http://www.resverlogix.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees25

Key Executives

NameTitlePayExercisedYear Born
Mr. Donald J. McCaffreyCo-Founder, Chairman, Pres, CEO & Sec.505.2kN/AN/A
Mr. Aaron Bradley Cann C.A., CPA, CA, CPA, CBVChief Financial Officer281.8kN/AN/A
Mr. Kenneth Eugene Lebioda BASr. VP of Bus. & Corp. Devel.264.6kN/AN/A
Dr. Michael SweeneySr. VP of Clinical Devel.525.29kN/A1961
Dr. Ewelina KulikowskiSr. VP of R&D250kN/AN/A
Dr. Norman C.W. Wong B.Sc., FRCPC, M.Sc., B.Sc (Hon), M.Sc, M.D., FRCP(Co-Founder, Chief Scientific Officer & Chairman of the Scientific Advisory BoardN/AN/AN/A
Mr. Paul MoonVP of Investor Relations & CommunicationsN/AN/AN/A
Sarah ZapotichnyDirector of Investor Relations & Corp. CommunicationsN/AN/AN/A
Dr. Jan O. JohanssonSr. VP of Medical AffairsN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Resverlogix Corp. operates as a late-stage clinical biotechnology company. The company is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trials for patients with cardiovascular, chronic kidney, end-stage renal, neurodegenerative, fabry, peripheral artery, and other orphan diseases, as well as diabetes mellitus. Resverlogix Corp. is headquartered in Calgary, Canada.

Corporate Governance

Resverlogix Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.